Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients

Mutations of the transcription factor FOXL2, involved in cranio‐facial and ovarian development lead to the Blepharophimosis‐Ptosis‐Epicanthus Inversus Syndrome (BPES) in human. Here, we describe nine mutations in the open reading frame of FOXL2. Six of them are novel: c.292T>A (p.Trp98Arg), c.323T>C (p.Leu108Pro), c.650C>G (p.Ser217Cys) and three frameshifts. We have performed localization and functional studies for three of them. We have observed a strong cytoplasmic mislocalization induced by the missense mutation p.Leu108Pro located in the forkhead (FKH) domain of FOXL2. In line with this, transcriptional activity assays confirmed the loss‐of‐function induced by this variant. Interestingly, the novel mutation p.Ser217Cys, mapping between the FKH and the polyalanine domain of FOXL2 and producing a mild eyelid phenotype, led to normal localization and transactivation. We have also modeled the structure of the FKH domain to explore the potential structural impact of the mutations reported here and other previously reported ones. This analysis shows that mutants can be sorted into two classes: those that potentially alter protein‐protein interactions and those that might disrupt the interactions with DNA. Our findings reveal new insights into the molecular effects of FOXL2 mutations, especially those affecting the FKH binding domain. © 2008 Wiley‐Liss, Inc.

[1]  B. Benayoun,et al.  The mutations and potential targets of the forkhead transcription factor FOXL2 , 2008, Molecular and Cellular Endocrinology.

[2]  R. Veitia,et al.  Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. , 2007, Human molecular genetics.

[3]  J. Dausset,et al.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics , 2007, Proceedings of the National Academy of Sciences.

[4]  R. Veitia,et al.  A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction , 2006, Human Genetics.

[5]  K. Davies,et al.  Functional genetic analysis of mutations implicated in a human speech and language disorder. , 2006, Human molecular genetics.

[6]  M. Walter,et al.  The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. , 2005, Human molecular genetics.

[7]  M. Pannetier,et al.  Ovarian-specific expression of a new gene regulated by the goat PIS region and transcribed by a FOXL2 bidirectional promoter. , 2005, Genomics.

[8]  R. Veitia,et al.  A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation , 2004, Journal of Medical Genetics.

[9]  D. Schlessinger,et al.  Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. , 2004, Human molecular genetics.

[10]  Katrin Anlag,et al.  The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance , 2004, Development.

[11]  M. Walter,et al.  Structural and functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1. , 2003, Human molecular genetics.

[12]  R. Veitia,et al.  A sigmoidal transcriptional response: cooperativity, synergy and dosage effects , 2003, Biological reviews of the Cambridge Philosophical Society.

[13]  R. Veitia,et al.  Evolution and expression of FOXL2 , 2002, Journal of medical genetics.

[14]  R. Veitia,et al.  FOXL2 mutation screening in a large panel of POF patients and XX males , 2002, Journal of medical genetics.

[15]  K. Devriendt,et al.  Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation. , 2001, Human molecular genetics.

[16]  D. Schlessinger,et al.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.

[17]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[18]  J. Zlotogora,et al.  The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. , 1983, American journal of human genetics.

[19]  Katja Nowick,et al.  Structure of the forkhead domain of FOXP2 bound to DNA. , 2006, Structure.

[20]  M. Walter,et al.  Essential structural and functional determinants within the forkhead domain of FOXC1. , 2004, Nucleic acids research.

[21]  Y. Nishi,et al.  Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. , 2001, Endocrinology.

[22]  M. Ashburner A Laboratory manual , 1989 .